Wearable sensors and earlier detection in hospital care

A patient’s condition can change between routine observations. A rising respiratory rate, falling oxygen saturation, altered movement or a subtle change in skin temperature may appear before a serious event becomes obvious. Wearable sensors give clinicians a continuous stream of physiological data, helping them identify early deterioration and decide when a closer assessment is needed.

For Australian hospitals, this technology is most useful when it strengthens clinical judgement rather than attempting to replace it. Research translation, careful implementation and evaluation are essential to ensure that sensor data improves outcomes for patients, families and carers. Networks such as the Brisbane Diamantina network can help connect researchers, health services and universities around practical models of care.

What wearable monitoring can detect

Hospital-grade wearable devices may track heart rate, respiratory rate, oxygen saturation, temperature, movement, posture and, in some cases, blood pressure or electrocardiographic signals. A patient recovering from surgery, infection or an acute respiratory illness can therefore be monitored between scheduled observations, including while sleeping or moving around the ward.

The value lies in trends rather than one isolated reading. A gradual increase in breathing rate, combined with a rising pulse and reduced activity, may indicate developing sepsis, respiratory compromise or worsening pain. Algorithms can flag these changes for review, while nurses and doctors interpret them alongside symptoms, examination findings, medication history and pathology results.

Wearable monitoring can be particularly relevant for patients at risk of falls, delirium or clinical decline. Movement sensors may show that someone who was walking independently has become unusually inactive. That signal could prompt an assessment for infection, sedation, dehydration or a change in cognition before a preventable incident occurs.

From raw signals to a clinical response

A sensor is useful only when a hospital has a clear response pathway. Data should flow into an electronic observation system or clinician dashboard, with alerts directed to the team responsible for assessment. Escalation protocols can specify when staff should repeat vital signs, contact a medical officer, activate a rapid response team or provide immediate treatment.

Poorly designed alerts create alarm fatigue. If thresholds are too sensitive, staff may receive frequent notifications that do not require intervention and begin to disregard them. Effective programs combine automated warnings with patient-specific ranges, acuity-based settings and regular review of false alarms, missed events and response times.

Implementation also depends on workflow. Devices must be comfortable, easy to clean and simple to apply during admission, transfer and discharge. Nurses need time and training to check placement, manage charging and explain the purpose of monitoring. Patients should know that a wearable supports observation but does not remove the need to report breathlessness, pain, dizziness or feeling suddenly unwell.

Benefits across Australian hospitals

Australia’s large metropolitan hospitals may be able to support sensor pilots through digital health teams, research offices and established data infrastructure. In Brisbane, the technology could assist high-turnover wards where staff monitor many patients with different levels of risk. It may also support earlier discharge when clinicians can see stable trends and patients meet appropriate clinical criteria.

Local realities matter. Patients may travel long distances from regional Queensland to tertiary services, while smaller hospitals can face workforce shortages and limited access to specialist review. Remote monitoring cannot substitute for local clinical care, yet reliable trend data may help teams recognise deterioration sooner and communicate a clearer picture during retrieval or consultation.

The Australian market includes wearable devices designed for hospitals, consumer fitness trackers and software platforms that connect with clinical systems. These products differ substantially in accuracy, cybersecurity, battery life and regulatory status. A device marketed to consumers should not automatically be treated as a diagnostic tool in a hospital. Procurement teams need evidence that the product performs adequately across different skin tones, body types, ages and levels of mobility.

Safety, privacy and patient trust

Continuous monitoring produces sensitive health information. Australian services must consider the Privacy Act 1988, applicable state and territory health privacy requirements, and the My Health Records Act 2012 where information enters the national record system. Queensland organisations also need governance processes that define who can access sensor data, how long it is retained and when it can be shared with another service.

Consent and communication should be practical and respectful. Patients need an explanation of what is being measured, why it matters, how alerts are handled and whether participation is voluntary where the program is being evaluated. Carers may also need guidance, particularly when a patient has cognitive impairment, limited English or difficulty managing the device.

Cybersecurity should be assessed from the sensor through to the hospital network and any external cloud platform. Encryption, access controls, software updates, incident response and vendor accountability are core safeguards. Where a device makes or supports a clinical decision, teams should also check its status with the Therapeutic Goods Administration and document how its performance is monitored after implementation.

Designing equitable and useful programs

Wearable sensors should be tested with the people who will use them. A device may be less reliable when a patient has tremor, reduced circulation, darker skin pigmentation, excessive sweating or a wound near the sensor site. Adhesive allergies, cultural preferences, disability and discomfort can affect whether monitoring is accepted and maintained.

Equity includes access to understandable information and culturally safe care. Aboriginal and Torres Strait Islander patients, older people, people experiencing homelessness and patients from culturally diverse communities may have different concerns about technology and data sharing. Co-design with consumers, carers and local clinicians can expose practical barriers that are invisible in a technical pilot.

The same principle applies beyond physical deterioration. Changes in sleep, activity and engagement may provide useful context for patients with mental health needs, although these signals must never be used to label a person or make unsupported predictions. Guidance on mental health integration reinforces the value of coordinated, person-centred care rather than isolated data points.

Measuring whether the technology works

A strong evaluation looks beyond the number of devices deployed. Hospitals should measure unplanned intensive care transfers, cardiac arrests, rapid response calls, length of stay, readmissions, falls, staff workload and patient experience. They should compare results with a suitable baseline and examine whether benefits are consistent across wards and patient groups.

Researchers can also assess technical performance, including signal quality, missing data, alert sensitivity and the time from notification to clinical review. Qualitative interviews with nurses, doctors, patients and carers can show whether the system fits real care routines. Economic analysis may reveal whether fewer adverse events offset equipment, training, maintenance and integration costs.

Successful translation requires a staged approach: begin with a defined clinical problem, test the technology in a limited setting, refine the workflow and expand only when safety and value are demonstrated. Partnerships between Queensland health services, universities, consumers and technology providers can turn promising sensor data into dependable bedside care.

Support evidence-led wearable monitoring by bringing clinicians, researchers, patients and carers into the design and evaluation process. With clear governance and a focus on meaningful clinical action, Australian hospitals can use continuous sensing to recognise change earlier and respond with greater confidence.